Five new companies advanced as finalists representing the ASPS plastic surgery track in the Medtech 2025 innovative competition to defend technologies that improve the results for patients. Each startup will participate in the Comprehensive Program, designed to help grow new promising companies focused on health, diagnosis and digital health technology.
The new selected plastic surgery companies to advance in this articular effort between the American Society of Plastic Surgeons (ASP) and Medtech Innovator (MTI) include medical technologies, medical, Bio Insoma, Magsorbeo Biomedical and Restiyx Medical. The five finalists join a field of 60 new additional companies around the world that will compete for an action of $ 800,000 in the duration of the four -month program financing awards.
“We commit ourselves in ASP to promote innovation that improves the life of our patients and advances the future of plastic surgery,” said Alan Matarso, MD, FACS, president of the Foundation of Plastic Surgery. ” and both formative and both formative and both formative and Borthytrive and Borthytrive and Structural Borthard and both trainers and both trainers and both care when associated with companies in the initial stage through the MTI/ASPS accelerator.
There were 96 companies that requested the plastic surgery track in the MTI competition this year, and 12 advanced to the phase of lens lens trial, where the five main ones were selected to represent ASP and the plastic surgery track. Each of the five cohorts participants of the MTI/ASPS plastic surgery accelerator will be presented in plastic surgery the meeting in New Orleans from October 9 to 12 and will receive Tutoring of ASP surgeons and associated businessmen. They will also participate in the Medtech Innovator corporate mentoring program, where they will be paired with senior industry leaders to collect ONDEP, in depth and personalized tutoring and support.
This year’s event marks the fourth year of the ASPS/MTI Association, but since the launch of Medtech Innovator in 2013, more than 500 colleagues have completed the program, resulting in more than 200 approvals and authorizations of the FDA and $ 6.8 billion.
About Medtech Innovator
Based in Los Angeles, Medtech Innovator is the largest accelerator in the world of medical technology companies and the main non -profit starting accelerator in the medical technology industry. Its mission is to improve the lives of patients by accelerating the growth of companies that are transforming the health system. In collaboration with 35 corporate partners, as well as a broader network of more than 1,000 industry executives, including investors, business development representatives and other interested parties, Medtech Innovator offers new companies and individualized tutorials and individualized comments, financing opportunities and continuous commitment to their colleagues and advisors.